Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tahir Latif
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
CD20 positive diffuse large b-cell lymphoma undergoing treatment with systemic rituximab in combination with CHOP, CHOEP, or EPOCH and deemed high risk of CNS relapse and eligible for central nervous system prophylaxis with intrathecal therapy.
You may not be if
Primary central nervous system lymphoma or established secondary central nervous system disease.
History of spinal surgery and/or ineligible for intrathecal injections.
